An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone shared their personal progress chart after starting Mounjaro in January 2025. In plain terms, this is a single person's timeline showing things like weight, medication doses, and maybe how they felt over time. It’s a personal story, not a scientific trial. It can be helpful as an example, but it doesn’t prove how the drug works for everyone. Mounjaro is the brand name for tirzepatide. It’s a prescription medicine that acts like two natural gut hormones put together: one that helps control blood sugar and another that makes you feel full. Doctors prescribe it for type 2 diabetes and it’s also used off-label for weight loss in some cases. It’s given by injection under the skin, usually once a week, and the dose can be adjusted over time. The chart shows one person’s results after they began Mounjaro — probably tracking weight, dose changes, and maybe side effects or other markers. Because this is a single-patient chart, it can show a timeline where weight goes down as dose goes up, or where side effects appeared when the dose changed. But that’s all it is: one person’s experience. It doesn’t tell us how common those results are, how long they last for most people, or whether the same pattern would happen with different diets, activity levels, or medical conditions. Why does this matter? Personal charts can be motivating and informative for people considering the drug. They give a realistic look at how dosing is gradual, how progress can vary week to week, and how people might manage expectations. For someone with type 2 diabetes or someone talking to their doctor about weight loss options, seeing a peer’s timeline can spark useful questions to ask a clinician about benefits and next steps. There are important caveats. A single chart can’t show safety or long-term outcomes. Common side effects of tirzepatide include nausea, diarrhea, and stomach upset; more serious risks are possible and need medical oversight. It’s a prescription drug — dosing and suitability should be decided by a healthcare professional. People who are pregnant, have a history of certain thyroid cancers, or have specific medical conditions should not take it without careful medical review. Finally, because this is personal and not a controlled study, other factors like diet, exercise, sleep, and other medications may explain some or all of the changes. Bottom line: The chart is an interesting personal snapshot of starting Mounjaro, but it’s not proof of what will happen for you — talk to your doctor to understand the likely benefits and risks.
Source: r/Mounjaro